DAPK1在急性肺损伤炎症反应中的作用及机制研究
本文选题:急性肺损伤 + 死亡相关蛋白激酶1 ; 参考:《第三军医大学》2017年硕士论文
【摘要】:研究背景:急性肺损伤(ALI)/急性呼吸窘迫综合征(ARDS)是临床上较为常见的由创伤、严重感染等多种内外因素诱发的以难治性低氧血症为特征的危重症,目前认为ALI/ARDS的本质是一种炎症,其发病与炎症的失控密切相关。尽管近年来人们对ARDS的研究不断深入,诊疗技术有明显提升,其病死率仍居高不下[1-2]。因此,深入研究其发病机制,寻求新的有效的治疗靶点,开发新的药物和治疗手段,减轻过度炎症反应以降低发病率和死亡率显得尤为重要。死亡相关蛋白激酶1(DAPK1)是一种钙调蛋白(CaM)调节的丝氨酸/苏氨酸蛋白激酶,包含有多个功能区域,作为一种凋亡正性调节因子在多种途径诱导引起的凋亡中扮演着重要角色[3-4],还参与了炎症的调节和自噬[5-6]。有研究发现,DAPK1参与了脑及肾的缺血性急性损伤疾病过程[7-8]。然而,DAPK1是否也参与急性肺损伤的发病过程,是否参与其炎症失控的调节尚未见报道。因此,本课题拟采用脂多糖(LPS)构建急性肺损伤模型及LPS诱发的巨噬细胞炎症模型,观察DAPK1的表达变化,并通过下调DAPK1表达后观察细胞自噬水平、促炎基因表达及炎症因子表达水平,从而探讨DAPK1在急性肺损伤发病及炎症调节中的作用及机制。研究目的:1.明确DAPK1在急性肺损伤时的表达及其在炎症失控中的作用;2.探讨DAPK1在控制炎症反应过程中的潜在机制。方法:1.DAPK1在急性肺损伤小鼠肺组织中的表达研究通过LPS(10mg/kg)腹腔注射构建急性肺损伤小鼠模型,采取HE染色观察肺损伤病理改变情况,免疫组化、Western blot及Real-time PCR等技术明确DAPK1在急性肺损伤小鼠肺组织中的表达变化及定位,ELISA检测血浆促炎因子水平变化。2.DAPK1对LPS诱导小鼠巨噬细胞炎症反应的调控作用及机制研究Western blot及Real-time PCR技术观察LPS作用RAW264.7巨噬细胞后,DAPK1随时间和浓度改变的表达情况;构建DAPK1 shRNA腺相关病毒,感染巨噬细胞后应用Western blot观察对NK-KB启动子活性、下游p38-mTOR信号通路、自噬相关蛋白LC3、p62的影响,Real-time PCR检测炎症因子IL-6、TNF-α和IL-1β的表达变化。3.下调DAPK1的表达对急性肺损伤炎症反应的影响采取LPS腹腔注射构建急性肺损伤模型,使用DAPK1特异性抑制剂TC-DAPK6预处理小鼠抑制DAPK1表达,Western blot检测TC-DAPK6对DAPK1的抑制效果,HE染色观察DAPK1抑制后对LPS诱导肺损伤的病理改变情况,Western blot及Real-time PCR观察DAPK1抑制后对NF-κB P65及促炎因子水平的影响,应用Kaplan-Meier生存分析研究不同处理组小鼠的生存时间。结果:1.成功构建了急性肺损伤小鼠模型,DAPK1在正常小鼠肺组织中仅少量表达,在急性肺损伤3h时DAPK1表达较对照组升高(P0.05),至24h达到最高水平(P0.05)。炎症因子TNF-α、IL-6急性肺损伤时较对照组表达明显升高(P0.05),在12-24h维持在较高水平(P0.05)。随着LPS处理时间的延长,肺湿干重比逐渐升高(P0.05)。2.随着LPS浓度的不断升高,刺激RAW264.7巨噬细胞DAPK1表达逐渐增加(P0.05)。在LPS刺激6h后开始上升(P0.05),至24h达到最高水平(P0.05),至48h表达有所下降(P0.05)。此外,LPS处理RAW264.7细胞后,NF-κB启动子活性以及炎症因子IL-6、IL-1β、TNF-α的表达显著升高。通过AAV-DAPK1 shRNA转染下调巨噬细胞DAPK1表达后,NF-κB启动子活性明显下降(P0.05),同时P38-mTOR表达受到抑制,LC3 II/I上调,而p62表达减少(P0.05),自噬激活。此外,促炎因子IL-1β、IL-6、TNF-α表达水平也明显下降(P0.05)。3.TC-DAPK6特异性抑制DAPK1表达后,小鼠肺组织病理损伤较单独LPS组明显减轻,DAPK1表达受抑制后NF-κB p65表达明显下降(P0.05),血浆中促炎因子TNF-α、IL-6水平明显低于LPS组(p0.05),肺湿干重比显著降低。通过Kaplan-Meier生存分析发现,DAPK1抑制后小鼠的生存期显著长于LPS组(p0.01)。结论:1.DAPK1在LPS诱导的急性肺损伤中表达明显增加,可能参与急性肺损伤的发病。2.DAPK1通过调控P38-mTOR信号通路抑制巨噬细胞自噬以及激活NF-κB炎症信号通路,从而参与急性肺损伤的疾病过程。3.体内研究进一步证实DAPK1可通过激活NF-κB炎症信号通路,促进ARDS的发生发展。
[Abstract]:Background: acute lung injury (ALI) / acute respiratory distress syndrome (ARDS) is a clinically common critical disease characterized by multiple internal and external factors such as trauma and severe infection. It is considered that the essence of ALI/ARDS is a kind of inflammation, which is closely related to the loss of control of inflammation. The research of ARDS has been deepened, the diagnosis and treatment technology has been improved obviously and its mortality is still high, so it is still high [1-2].. Therefore, it is particularly important to study its pathogenesis, seek new effective therapeutic targets, develop new drugs and treatment methods, reduce the excessive inflammatory reaction in order to reduce the incidence and death rate. Death related protein kinase 1 (DAPK1) It is a serine / threonine protein kinase regulated by calmodulin (CaM), which contains multiple functional regions and plays an important role in apoptosis induced by multiple pathways as a positive regulator of apoptosis, [3-4]. It also participates in the regulation of inflammation and autophagic [5-6].. DAPK1 is involved in the acute ischemic loss of brain and kidney. It is not reported whether DAPK1 is involved in the pathogenesis of acute lung injury, however, whether it is involved in the regulation of acute lung injury, and it is not reported that it is not reported to participate in the regulation of inflammation. Therefore, we should use lipopolysaccharide (LPS) to construct acute lung injury model and LPS induced macrophage inflammation model, observe the expression changes of DAPK1, and observe the expression of DAPK1 by decreasing the expression of DAPK1. The level of autophagy, proinflammatory gene expression and expression of inflammatory factors in order to explore the role and mechanism of DAPK1 in the pathogenesis and regulation of acute lung injury. 1. the purpose of this study is to clarify the expression of DAPK1 in acute lung injury and its role in the control of inflammation, and 2. to explore the potential mechanism of DAPK1 in the process of controlling the inflammatory response. The expression of 1.DAPK1 in lung tissue of mice with acute lung injury was studied by intraperitoneal injection of LPS (10mg/kg) to construct a mouse model of acute lung injury. The pathological changes of lung injury were observed by HE staining, immunohistochemistry, Western blot and Real-time PCR were used to clarify the expression and localization of DAPK1 in the lung tissue of mice with acute lung injury, ELISA. The regulatory role of plasma proinflammatory factor level changes.2.DAPK1 on LPS induced macrophage inflammatory response and its mechanism study Western blot and Real-time PCR technology to observe the expression of DAPK1 with time and concentration after LPS action RAW264.7 macrophages; construct DAPK1 shRNA gland associated virus, infected macrophages and apply Weste The effect of RN blot on NK-KB promoter activity, downstream p38-mTOR signaling pathway, the effect of autophagy related protein LC3, p62, Real-time PCR detection of the expression of inflammatory factors IL-6, TNF- alpha and IL-1 beta, the expression of TNF- A and IL-1 beta has an effect on acute lung injury by constructing an acute lung injury model by intraperitoneal injection. The preparation TC-DAPK6 pretreated mice to inhibit the expression of DAPK1, Western blot was used to detect the inhibitory effect of TC-DAPK6 on DAPK1. The pathological changes of LPS induced lung injury after DAPK1 inhibition were observed by HE staining. The effect of Western blot on the inhibition of DAPK1 and the level of proinflammatory factors after inhibition of Western blot were studied. The survival time of the mice in the same treatment group. Results: 1. a mouse model of acute lung injury was successfully constructed. Only a small amount of DAPK1 was expressed in the lung tissue of normal mice. The expression of DAPK1 in the acute lung injury was higher than that in the control group (P0.05), to the highest level (P0.05) to 24h (P0.05). The expression of inflammatory factor TNF- A and IL-6 in acute lung injury were significantly higher than those in the control group (P). 0.05) at the high level of 12-24h (P0.05). With the prolongation of LPS treatment time, the ratio of wet dry weight of lung gradually increased (P0.05).2. with the increase of LPS concentration, and the expression of DAPK1 in RAW264.7 macrophages increased gradually (P0.05). In addition, after LPS treatment of RAW264.7 cells, the activity of NF- kappa B promoter and the expression of IL-6, IL-1 beta, and TNF- alpha were significantly increased. The activity of NF- kappa B promoter was significantly decreased after AAV-DAPK1 shRNA transfection, and the expression was inhibited and autophagy stimulated. In addition, the expression level of IL-1 beta, IL-6, TNF- alpha was also significantly decreased (P0.05).3.TC-DAPK6 specific inhibition of DAPK1 expression, the pathological damage of lung tissue in mice was significantly lower than that in the single LPS group, and the p65 expression of NF- kappa B decreased significantly after the inhibition of DAPK1 expression (P0.05), and the level of proinflammatory factor alpha in the plasma was significantly lower than that of the lung. The Kaplan-Meier survival analysis showed that the survival time of DAPK1 inhibited mice was significantly longer than that of the LPS group (P0.01). Conclusion: 1.DAPK1 was significantly increased in the acute lung injury induced by LPS, and may be involved in the pathogenesis of acute lung injury by regulating the autophagy of macrophages and activating N by regulating the P38-mTOR signaling pathway. The F- kappa B inflammatory signaling pathway, which is involved in the disease process of acute lung injury, has further confirmed that DAPK1 can promote the development of ARDS by activating the NF- kappa B signaling pathway.
【学位授予单位】:第三军医大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R563.8
【相似文献】
相关期刊论文 前10条
1 李洪霞;白介素-10对急性肺损伤的保护作用[J];国外医学.呼吸系统分册;2000年02期
2 刘宝军 ,赵艺亭 ,白桂云;急性肺损伤的诊治进展[J];医学综述;2001年12期
3 ;全球首个急性肺损伤治疗药西维来司他在日本获得许可[J];中国新药杂志;2002年07期
4 ;急性肺损伤治疗药西维来司他在日本获得许可[J];中国新药杂志;2002年12期
5 郑鹏,杨径,申群喜;沐舒坦对急性肺损伤患者保护作用的研究[J];华夏医学;2002年03期
6 陈朝辉,赵文韬;角化细胞生长因子与急性肺损伤[J];广西医学;2003年09期
7 马晓薇,曹相原;肺表面活性物质蛋白A与急性肺损伤[J];宁夏医学院学报;2004年03期
8 赵中江,孟新科,杨径;沐舒坦对急性肺损伤肺保护作用的研究[J];中国现代医学杂志;2004年22期
9 王殿华,刘旭,凌亦凌;中性粒细胞弹性蛋白酶与急性肺损伤[J];国外医学.呼吸系统分册;2004年06期
10 吴穗晶,杜欣,陆泽生,钟立业,龙怡;粒细胞集落刺激因子动员外周血造血干细胞致急性肺损伤1例[J];白血病.淋巴瘤;2004年06期
相关会议论文 前10条
1 武庆平;金胜威;刘东;桂平;尚游;冯丹;姚尚龙;;急性肺损伤研究新思路抗炎和促炎症消退相结合[A];2010中华医学会全国麻醉学术年会论文汇编[C];2010年
2 祝胜美;张红刚;;输血相关性急性肺损伤[A];2004年浙江省麻醉学学术年会论文汇编[C];2004年
3 张寒钰;谢苗荣;;输血相关性急性肺损伤及其新进展[A];第十一次全国急诊医学学术会议暨中华医学会急诊医学分会成立二十周年庆典论文汇编[C];2006年
4 蒋龙元;;抗凝、抗炎双向调节治疗在急性肺损伤的应用前景[A];《中华急诊医学杂志》第八届组稿会暨急诊医学首届青年论坛论文汇编[C];2009年
5 高冬娜;张_g;;急性肺损伤研究进展[A];2009年全国危重病急救医学学术会议论文汇编[C];2009年
6 梁子敬;黄伟青;;表皮生长因子对内毒素型急性肺损伤的作用实验研究[A];第五届全国灾害医学学术会议暨常州市医学会急诊危重病及灾害医学专业委员会首届年会学术论文集[C];2009年
7 潘鹏飞;于湘友;;侧卧位通气对急性肺损伤/急性呼吸窘迫综合征患者肺复张容积的影响[A];第三届重症医学大会论文汇编[C];2009年
8 伍峻松;王沈华;周文;陈金明;张茂;徐少文;干建新;赵小纲;;严重创伤合并急性肺损伤恶化进展至急性呼吸窘迫综合征的临床危险因素分析[A];第七届全国创伤学术会议暨2009海峡两岸创伤医学论坛论文汇编[C];2009年
9 高冬娜;张_g;;核因子-κB与急性肺损伤治疗[A];2010全国中西医结合危重病、急救医学学术会议论文汇编[C];2010年
10 胡宗风;孙海晨;邵旦兵;李百强;聂时南;;急性肺损伤血管内皮保护作用的临床研究[A];中华医学会急诊医学分会第十三次全国急诊医学学术年会大会论文集[C];2010年
相关重要报纸文章 前9条
1 熊学莉邋通讯员 曾理;急性肺损伤早诊早治降低病死率[N];健康报;2008年
2 郭姜宁 常亮 王晓静;高海拔地区急性肺损伤防治难题攻克[N];科技日报;2003年
3 郭姜宁 常亮 王晓静;急性肺损伤防治难题攻克[N];医药导报(中药报);2003年
4 ;Calfactant在儿科急性肺损伤中的疗效[N];医药经济报;2005年
5 张国民;首个治疗“非典”新药进入临床研究[N];中国医药报;2003年
6 记者 张晓松;治非典新药首次获批临床试验[N];新华每日电讯;2003年
7 邹争春 记者 陈磊;我国学者发现新生儿急性肺损伤新病因[N];科技日报;2013年
8 李山;德发现致命性输血并发症致病机理[N];保健时报;2010年
9 李山;德找到致命性输血并发症致病机理[N];科技日报;2009年
相关博士学位论文 前10条
1 郭亮;ANGPTL4在LPS诱导的急性肺损伤中的作用及机制研究[D];第三军医大学;2015年
2 宫国华;三唑类化合物的合成及心房应力调节和抗炎作用研究[D];延边大学;2015年
3 孙建斌;双链核糖核酸(dsRNA)的产生及其调控的信号通路在急性肺损伤发生发展中的分子机制研究[D];第四军医大学;2015年
4 苏玉杰;保肺解窘合剂治疗脓毒症致急性肺损伤的临床研究[D];成都中医药大学;2015年
5 张勇;褪黑素通过抑制NLRP3炎性小体减轻小鼠急性肺损伤[D];中国农业大学;2016年
6 祝华;脐带间充质干细胞治疗急性肺损伤模型的机制探讨[D];重庆医科大学;2015年
7 贾春娥;阴离子交换转运蛋白Pendrin在急性肺损伤小鼠模型中的作用和干预研究[D];北京协和医学院;2016年
8 杜松林;α1-抗胰蛋白酶对体外循环术后急性肺损伤的保护作用研究[D];南方医科大学;2016年
9 王勤;解偶联蛋白2在脂多糖诱导的急性肺损伤中的作用及机制研究[D];第三军医大学;2015年
10 赵燕;雷帕霉素通过抑制Th17细胞分化减轻LPS诱导的小鼠急性肺损伤[D];重庆医科大学;2016年
相关硕士学位论文 前10条
1 刘霞;DAPK1在急性肺损伤炎症反应中的作用及机制研究[D];第三军医大学;2017年
2 刘安;间充质干细胞在急性肺损伤/急性呼吸窘迫综合征中的研究进展[D];蚌埠医学院;2013年
3 何鑫敏;氦氧通气对急性肺损伤病人的治疗作用及机制[D];福建医科大学;2015年
4 任鸿昌;MMP-9、AQP-1、AQP-5在胰蛋白酶导致的急性肺损伤中的表达及意义[D];安徽医科大学;2015年
5 宣国平;Ang2在急性肺损伤中的作用及其机制研究[D];安徽医科大学;2015年
6 侯林义;抗CD14单克隆抗体对脓毒症急性肺损伤大鼠肺泡巨噬细胞内NF-κB(p65)影响的研究[D];山西医科大学;2015年
7 冯迪;PPAR γ通路参与电针预处理对急性肺损伤的保护作用及相关机制[D];苏州大学;2015年
8 焦艳;PGC-1α在急性肺损伤中的作用及机制研究[D];第三军医大学;2015年
9 庄佩佩;LPS诱导小鼠急性肺损伤及MgSO_4对其保护作用机制的研究[D];宁夏大学;2015年
10 江伟哲;右美托咪定对大鼠急性肺损伤时肺组织NF-κB活性及细胞因子的影响[D];四川医科大学;2015年
,本文编号:1885503
本文链接:https://www.wllwen.com/yixuelunwen/huxijib/1885503.html